8x8 is a cloud provider of enterprise Software-as-a-Service communications solutions, that enable businesses of all sizes to communicate across voice, video meetings, chat and contact centers. From one proprietary cloud technology platform, customers have access to unified communications, team collaboration, video conferencing, contact center, data and analytics and other services. The 8x8 technology platform provides customers with primary technology integrations within their existing infrastructure. The company provides a variety of stand alone services and offerings including 8x8 Virtual Office; 8x8 Contact Center; 8x8 Meetings; 8x8 Team Messaging; and Script8? (Scripting Engine).

AT Lease SAE Formerly known as Al Tawfeek Company for Financial Leasing. Al Tawfeek Company for Financial Leasing is an Egypt-based financial institution specialized in financial leasing. It is an Islamic Shariaa compliant leasing company, which provides a variety of international leasing solutions and products. The Company offers its products under the following categories: Financial Lease/Capital, which is a full payout lease used to finance the purchase of different kinds of assets; True Lease, which is offered for vehicles and it is primarily designed for businesses; Structured Lease, which includes acquisition finance and leveraged buyouts, as well as Vendor Lease, which is a finance program for vendors whereby the Company finances the vendors' clients according to a mutually agreed legal framework. Al Tawfeek Company for Financial Leasing is an affiliate of Dallah Al-Baraka Group.

Alkermes is a biopharmaceutical company. Co.'s products include: ARISTADA, which is an extended-release injectable suspension for the treatment of schizophrenia; VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence; INVEGA SUSTENNA/XEPLION, and RISPERDAL CONSTA, which is for the treatment of schizophrenia and for the treatment of schizoaffective disorder; AMPYRA/FAMPYRA, which is a treatment to improve walking in adults with multiple sclerosis; and BYDUREON is for the treatment of type 2 diabetes. Co.'s product candidate include Aripiprazole Lauroxil Two-Month Dose for the treatment of schizophrenia, among others.

Alpine Immune Sciences is a clinical-stage immunotherapy company focusing on a new wave of immune therapeutics, creating potentially multifunctional immunotherapies to improve patients' lives via protein engineering technologies. The company has two keyprograms, ALPN-101 for autoimmune/inflammatory diseases, and ALPN-202 for the treatment of cancer. The company's proprietary scientific platform uses a process known as directed evolution to convert native immune system proteins from the Immunoglobulin Super Family, into multi-targeted therapeutics potentially capable of modulating the human immune system.

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer immunotherapies. The company has four clinical-stage product candidates: AB928, which is an orally bioavailable, reversible antagonist of the adenosine 2a and adenosine 2b receptors; AB680, which is a reversible and selective inhibitor of the CD73 enzyme; AB122, which is a human antibody with similar binding affinity and other characteristics to the marketed anti-PD-1 antibodies pembrolizumab and nivolumab; and AB154, which is a humanized antibody that inhibits an immune checkpoint target involved in a pathway that plays both inhibitory and stimulatory roles in the immune system.

Bill.com is a holding company. Through its subsidiaries, the company is a provider of software-as-a-service, cloud-based payments products, which allow users to automate accounts payable and accounts receivable transactions and enable users to easily connect with their suppliers and/or customers to do business, manage cash flows and improve back office efficiency.

BioCryst Pharmaceuticals is a biotechnology company that discovers oral, small-molecule medicines. The company focuses on oral treatments for rare diseases in which unmet medical needs exist and an enzyme plays the main role in the biological pathway of the disease. The company's drug/drug candidates include: Berotralstat (BCX7353), an oral serine protease inhibitor targeting kallikrein that is being developed as a once-daily oral therapy for the prevention of Hereditary Angioedema; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; and BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive.

BridgeBio operates as a bio technology company. The company focuses on development of medicines for genetic diseases. The company serves patients worldwide.

CarGurus is an online automotive marketplace connecting buyers and sellers of new and used cars. The company's selection of car listings provides a number of car listings available on the main United States online automotive marketplaces. In addition to the United States, the company operates online marketplaces under the CarGurus brand in Canada, the United Kingdom, Germany, Italy and Spain. Through its marketplace, the company provides consumers with information that helps them find the relevant car for their needs. A user accesses the company's marketplace through its websites or, in the United States and certain international markets, by using the company's mobile applications.

Chewy is a pure play e-commerce business geared toward pet products for dogs, cats, fish, birds, small pets, horses, and reptiles. The company serves its customers through its retail website, www.chewy.com, and its mobile applications and focuses on delivering exceptional customer service, a large selection of high-quality pet food, treats and supplies, price, convenience (including Chewy's Autoship subscription program), fast shipping, and hassle-free returns.

Cohu provides semiconductor test equipment and services. The company's products include semiconductor test, which is used for wafer level and device package testing; semiconductor handlers, which are used to automate the testing and inspection of packaged semiconductor devices; thermal sub-systems, which provide temperature control of the integrated circuit during the testing process; bare board printed circuit board (PCB) test systems, which are used to test pre-assembly PCBs; interface products, which consist of test contactors and probe pins; spares and kits, which provide consumable, non-consumable and spare items; and services, which performs installations and maintenance of systems sold.

Cowen is a financial services firm. The company provides investment management, investment banking, research, sales and trading, prime brokerage, global clearing and commission management services through its two business segments: investment management, which includes advisers to investment funds (including privately placed hedge funds, real estate funds, and private equity structures), managed accounts, registered funds and a significant portion of the company's proprietary capital; and investment bank, which provides global capital markets origination and domain knowledge-driven research, sales and trading platform for institutional investors, global clearing and commission management services.

CVR Partners owns, operates, and grows its nitrogen fertilizer business. The company produces and distributes nitrogen fertilizer products, which are used by farmers to improve the yield and quality of their crops. The company's main products are ammonia and urea ammonium nitrate (UAN), an aqueous solution of urea and ammonium nitrate used as a fertilizer. The company's products are sold on a wholesale basis. The company produces nitrogen fertilizer products at two manufacturing facilities, which are located in Coffeyville, KS and East Dubuque, IL. The company primarily markets UAN products to agricultural customers and ammonia products to agricultural and industrial customers.

Domo provides a platform that digitally connects people, data and systems in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company's platform provides access to data through a set of connection options, including connectors. The company's data warehouse, Adrenaline, stores data from across the business. Fusion is the company's data transformation engine that sorts customer data. The company's Explorer analytics suite allows users to analyze, display, share and interact with data through visualizations. With the Domo Appstore, APIs and developer tool kits, the company enables an ecosystem of partners to build applications on the platform.

Donnelley Financial Solutions is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, print and distribution solutions to public and private companies, mutual funds and other regulated investment firms. For corporate clients within its capital markets offerings, the company provides filing solutions that allow U.S. public companies to comply with applicable U.S. Securities and Exchange Commission regulations. The company operates in two business segments: U.S, which is comprised of capital markets, investment markets, and language solutions; and International, which includes operations in Asia, Europe, Canada, and Latin America.

Dropbox is a global collaboration platform that centralizes the flow of information between the products and services its users prefer. Dropbox allows individuals, teams, and organizations to collaborate. Anyone can sign up for free via the company's website or app, and upgrade to a paid subscription plan for additional features. Dropbox is a digital workspace where individuals and teams can create content, access it from anywhere, and share it with collaborators. The company also utilizes Amazon Web Services (AWS), for the remainder of its users' storage needs and to help deliver its services. These AWS datacenters are in the United States and Europe, which allows the company to localize where content is stored.

Enphase Energy is a global energy technology company. The company designs, develops, manufactures and sells home energy solutions that connect energy generation, energy storage and control and communications management on one platform. The company's semiconductor-based microinverter converts energy at the individual solar module level and, combines with its proprietary networking and software technologies to provide energy monitoring and control. The Enphase Home Energy Solution with IQ consists of four primary components: Enphase microinverters, the AC Battery?, an Envoy gateway, and Enlighten cloud-based software.

Evelo Biosciences is discovering and developing therapies designed to engage immune cells in the small intestine to drive therapeutic immune effects throughout the body for the treatment of inflammatory diseases and cancers. The company is developing monoclonal microbials, a modality of oral biologic medicines. The company initiates a clinical trial of its monoclonal microbial candidate in inflammatory diseases, EDP1066 and initiates a clinical trial for its inflammation candidate, EDP1815. The company is developing monoclonal microbial therapies in oncology. The company initiates its clinical trial of its oncology product candidate, EDP1503 in combination with KEYTRUDA? (pembrolizumab) in various oncology indications.

Frequency Therapeutics operates as a biotechnology company. The company discovers and develops medicines and small molecule drugs for the treatment of patients with skin disorders, muscle regeneration, and gastrointestinal diseases. The company serves health care sector in the United States.

Health Catalyst is a provider of data and analytics technology and services to healthcare organizations. The company designs, develops, and delivers healthcare software solutons for hospitals to manage operational, financial, clinical, and research data. The company serves customers in the State of Utah.

Infinera is a supplier of networking solutions comprised of networking equipment, software and services. The company's portfolio of solutions includes optical transport platforms, converged packet-optical transport platforms, optical line systems and disaggregated router platforms. Also, the company's product portfolio includes the Infinera DTN-X Family, the Infinera hiT 7300 platform, the Infinera mTera Series, the Infinera 7100 Series, the Infinera 7090 Series, and the Infinera XTM Series, among other. Software products include the Infinera Transcend Software Suite, which includes software-defined networking and network management software, and the company's converged network operating system routing software.

InfuSystem Holdings is a health care service provider. The company's main service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer and other disease states. The company also sells or rents new and pre-owned pole-mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for, oncology practices, as well as other site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others.

Inseego designs and develops mobile, Internet of Things and cloud solutions for enterprise verticals, service providers and small and medium-sized businesses. The company's range of products includes 4G and 5G mobile hotspots, wireless gateways and routers for IoT applications, 4G LTE hotspots and USB modems, integrated telematics and mobile tracking hardware devices. The company's software-as-a-service (SaaS) delivery platforms include its Ctrack platforms, which provide fleet, vehicle, aviation, asset and other telematics applications and its Device Management Solutions, a hosted SaaS platform that helps organizations manage the selection, deployment and spend of their wireless assets.

Manning & Napier is an independent investment management firm that provides its clients with a range of financial solutions and investment strategies. The company serves a client base of individuals and institutions, including 401(k) plans, pension plans, Taft-Hartley plans, endowments and foundations. The company provides equity, fixed income and a range of blended asset portfolios by employing various approaches. The company's investment management offerings include distinct separate account composites and mutual funds and collective investment trusts.

MongoDB operates as a general purpose database platform. The company's primary offerings are: MongoDB Enterprise Advanced, which includes the company's proprietary commercial database server, enterprise management capabilities, its graphical user interface, analytics integrations, technical support and a commercial license to its platform; MongoDB Atlas, which provides customers with automated provisioning and healing, system monitoring, managed backup and restore, default security and other features; and Community Server, which is a free-to-download version of the company's database that does not include all of the features of its commercial platform. The company also provides consulting and training to its customers.

Myers Industries manufactures a range of polymer products for industrial, agricultural, automotive, commercial and consumer markets. The company has two business segments: Material Handling and Distribution. The Material Handling segment manufactures polymer packaging containers, storage and safety products, and specialty molded parts. The brands within this segment include Buckhorn?, Akro-Mils?, Jamco Products, Ameri-Kart?, and Scepter. The company's Distribution segment includes the Myers Tire Supply?, Myers Tire Supply International? and Patch Rubber Company? brands. Within the Distribution Segment Co. sources and manufactures products for the tire, wheel and undervehicle service industry.

NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer (NK) cell to treat cancer and viral infectious diseases. NK cells are the body's first line of defense due to their innate ability to seek and destroy abnormal cells, such as cancer or virally-infected cells, without prior exposure or activation by other support molecules required to activate adaptive immune cells such as T-Cells. The company holds the exclusive right to commercialize activated NK cells, a commercially viable natural killer cell line, and a variety of genetically modified derivatives capable of killing cancer and virally infected cells.

ORBCOMM is a provider of Internet of Things (IoT) solutions, including network connectivity, devices, device management and web reporting applications. The company's IoT products and services are designed to track, monitor, control and enhance security for various assets, such as trailers, trucks, rail cars, sea containers, generators, fluid tanks, marine vessels, diesel or electric powered generators, oil and gas wells, pipeline monitoring equipment, irrigation control systems, and utility meters, in several industries including transportation and supply chain. The company also provides satellite Automatic Identification Service data services to assist in vessel navigation and to improve maritime safety.

Otonomy is a biopharmaceutical company. The company is engaged in the application of drug delivery technology to the ear, which addresses medical needs. The company's product candidates include: OTIVIDEX, a steroid in development for the treatment of Meniere's disease; OTO-313, a selective N-Methyl-D-Aspartate receptor antagonist in development for the treatment of tinnitus; OTO-413, a sustained exposure formulation of brain-derived neurotrophic factor in development for the repair of cochlear synaptopathy, an underlying pathology in age-related and noise-induced hearing loss that manifests as speech-in-noise hearing difficulty (problem understanding speech in a noisy setting); OTO-510; and OTO-6XX.

Progyny operates as a fertility benefits management company in the United States. The company offers patients a benefits solution with education and guidance from a Patient Care Advocate and access to a network of fertility specialists. The company also aims to reduce healthcare costs for employers through their operations.

ProPetro Holding is a holding company. Through its subsidiary, the company is engaged as an oilfield services company providing hydraulic fracturing and other services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. The company's operations are primarily focused in the Permian Basin. In addition to its core hydraulic fracturing operations, the company provides complementary well completion and production services, including cementing, coiled tubing, flowback services and drilling. The company conducts its business through five segments: hydraulic fracturing (inclusive of acidizing), cementing, coil tubing, flowback and drilling.

Provention Bio is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The company's principal product candidates include: PRV-031 (teplizumab, anti-CD3 mAb) for the interception of type 1 diabetes; PRV-015 (anti-IL-15 mAb) for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 (oral CSF-1R inhibitor) for the treatment of Crohn's disease; PRV-300 (anti-TLR3 mAb) for the treatment of ulcerative colitis; and PRV-3279 (humanized anti-CD32B and CD79B bispecific) for the treatment of lupus.

Schweitzer-Mauduit International is a producer of materials, including papers, nets and films. The company operates and manages two reportable segments based on product lines: Advanced Materials and Structures, which manufactures resin-based products used in applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets; and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.

SM Energy is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and natural gas liquids in the state of Texas. The company's operations are concentrated in the Midland Basin and South Texas.

Smartsheet is a cloud-based platform for work execution, enabling teams and organizations to plan, capture, manage, automate, and report on work at scale. Customers access their accounts online via a web-based interface or a mobile application. Some customers also purchase the company's other services, which primarily consist of consulting and training services. The company's products are comprised of: Smartdashboards, Smartportals, Smartcards, Smartgrids, Smartprojects, Smartcalendars, Smartforms, Smartautomation, Smartintegrations, Connectors, Control Center, Accelerators, Dynamic View, and Data Uploader.

SolarEdge Technologies designs, develops, and sells an intelligent inverter solution designed for power generation at the individual photovoltaic module level. The company's products consist mainly of power optimizers designed to maximize energy throughput from each and every module via constant tracking of Maximum Power Point individually per module; inverters, which invert direct current from the PV module to alternating current; a related cloud-based monitoring platform; and a storage solution that is used to increase energy independence and maximize self-consumption for homeowners by utilizing a battery that is sold separately by third party manufacturers, to store and supply power as needed.

Solaris Oilfield Infrastructure is a holding company. Through its subsidiaries, the company is a provider of supply chain management and logistics solutions for the oil and natural gas industry. The company's offerings include: system rental, which manufactures and rents equipment to manage the delivery, handling and storage of proppant and chemicals at the well site; field services, which provides trained personnel to maintain and support its systems, train its customers to operate the systems and assist in the transportation of its systems; and transloading services, which provides manifest and unit-train transloading services, as well as provides forward staging storage of regional and local proppant.

Translate Bio is a clinical-stage messenger RNA (mRNA) therapeutics company. The company is engaged in developing medicines to treat diseases caused by protein or gene dysfunction. Using its proprietary mRNA therapeutic platform (MRT platform), the company creates mRNA that encodes functional proteins. The company is developing its MRT product candidate for the lung, MRT5005, for the treatment of cystic fibrosi, and MRT5201, for the treatment of ornithine transcarbamylase deficiency.

Trupanion provides medical insurance for cats and dogs throughout the United States, Canada and Puerto Rico. The company operates in two business segments: subscription business and other business. The subscription business segment includes subscription fees for the company's medical insurance, which the company market to consumers. The other business segment is engaged in writing policies on behalf of third parties.

Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. The company's product categories are: biologics, which include Crysvita? (burosumab) for the treatment of X-linked hypophosphatemia and Mepsevii? (vestronidase alfa) for the treatment of Mucopolysaccharidosis VII; small molecules, which includes UX007 for the treatment of long-chain fatty acid oxidation disorders; and gene therapy, which includes DTX301 for the treatment of patients with ornithine transcarbamylase deficiency and DTX401 for the treatment of patients with glycogen storage disease type Ia.

Verisec AB is a Sweden-based company which provides security solutions for banking, government and business customers.

Walt Disney is an entertainment company. The company's segments are: Media Networks, which includes domestic cable networks, broadcast television network and domestic television stations, and television production and distribution; Parks, Experiences and Products, which includes theme parks and resorts, and consumer products operations; Studio Entertainment, which includes motion picture production and distribution, music production and distribution, and post-production services; and Direct-to-Consumer and International, which includes international television networks and channels, direct-to-consumer streaming services, and other digital content distribution platforms and services.

WideOpenWesta is an integrated provider of high-speed data, cable television, digital telephony services to residential customers and provides a range of products and services to business customers. The company's products are available either as a bundle or as an individual service to residential and business service customers. In the Midwest, the company provides services in Detroit and Lansing, MI; Chicago, IL; Cleveland and Columbus, OH; Evansville, IN and Baltimore, MD. The Southeastern markets include Augusta, Columbus, Newnan and West Point, GA; Charleston, South Carolina; Dothan, Auburn, Huntsville and Montgomery, AL; Knoxville, TN; and Panama City and Pinellas County, FL.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.

Zillow Group operates real estate and home-related brands on mobile and the web which focus on all stages of the home lifecycle: renting, buying, selling and financing. The company's portfolio of consumer brands includes Zillow, Trulia, Mortgage Lenders of America, StreetEasy, HotPads, Naked Apartments, RealEstate.com and Out East. The company operates a number of business brands for real estate, rental and mortgage personnel. The company provides advertising products and services for real estate, rental, and mortgage personnel that enable them to create and promote content for consumers. In addition, the company provides consumers with information products and services to enable them to make decisions about homes.